FLGT News and Press, Fulgent Genetics Inc. From 05/14/21

Fulgent Genetics (NASDAQ: FLGT) recently announced impressive first-quarter results. However, its stock remains well below the highs set earlier this year. In this Motley Fool Live video recorded on May 5 , Motley Fool contributors Keith Speights and Brian Orelli answer...

Fulgent produced another stellar quarter and while its Covid business will shrink, it isn't going away anytime soon as it shifts to asymptotic and surveillance testing. Meanwhile, the company is leveraging its success in Covid in its NGS business in multiple ways. The company is a...

Fulgent's Q2 2021 guidance is strong, but that implies that H2 2021 will not be very alluring. Bears are too dismissive of Fulgent's approximately $1 billion in cash on its balance sheet by year-end. A lot of moving parts and substantially, uncertainty remains, namely what sort of...

Investment gives Fulgent controlling ownership of its Chinese Joint Venture entity, FF Gene Biotech Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology company providing comprehensive testing solutions through...

iBio (IBIO) +33% on COVID-19 study update.Orgenesis (ORGS) +11% on Q1 results.Chemomab Therapeutics (CMMB) +12%.T2 Biosystems, Inc. (TTOO) +11% on Q1 results.ViewRay (VRAY) +12%.Epizyme (EPZM) +11% on Q1 results.CureVac N.V. (CVAC) +9%.Roku (ROKU) +9% on Q1 results.Da...

Investors might have begun to worry that Fulgent Genetics ' (NASDAQ: FLGT) freefall in recent months would never end. The genetic testing company's shares have plunged more than 50% from the highs set earlier this year. Those worries might die down somewhat now, though. Fulgent ...

Image source: The Motley Fool. Fulgent Genetics, Inc. Common Stock (NASDAQ: FLGT) Q1 2021 Earnings Call May 06, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Fulgent Genetics, Inc. Common Stock (FLGT) Q1 2021 Earn...

Fulgent Genetics, Inc. (FLGT) Q1 2021 Earnings Conference Call May 06, 2021, 16:30 ET Company Participants Nicole Borsje - The Blueshirt Group Ming Hsieh - Chairman, CEO & President Brandon Perthuis - Chief Commercial Officer Paul Kim - CFO Conference Call Participants Poon Mah - Piper Sa...

Fulgent Genetics (FLGT): Q1 Non-GAAP EPS of $6.59 beats by $0.89; GAAP EPS of $6.52 beats by $0.66.Revenue of $359.43M (+4537.8% Y/Y) beats by $37.92M.2021 outlook:  Raises full year total revenue outlook to $830 million from $800 million, representing growth of 97% year over yearRaises ...

First Quarter 2021 Results : Record Revenue of $359.4 million, growing more than 4,500% year-over-year Record Billable tests delivered approximately 3.8 million, or 290 times the volume of first quarter of 2020 Gross Margin improved approximately 32 percentage points y...